| 5.88 |  +0.02 / +0.34% |
As of 4:02pm ET | Day’s Change |
| 5.84 |  -0.0375 / -0.64% |
Volume: 26.2K |
| Regulators Want Drug Companies to Be Honest About FDA Mar 04 / TheStreet.com |
| Previous close | 5.86 |
| Today’s open | 5.78 |
| Day’s range | 5.73 - 5.94 |
| Volume | 396,541 |
| Average volume (3 months) | 613,361 |
| Market cap | $304.6M |
| Dividend yield | -- |
| Earnings growth (last year) | -85.29% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | 0.00% |
| P/E ratio | NM |
| Price/Sales | 5,460.76 |
| Price/Book | 7.43 |
| Today’s change | Today’s % change | |
|---|---|---|
| ADMSAdamas Pharmaceutica... | -0.54 | -3.10% |
| SGYPSynergy Pharmaceutic... | -0.10 | -3.12% |
| VVUSVIVUS Inc | -0.08 | -2.79% |
| SNTASynta Pharmaceutical... | -0.14 | -5.24% |
| Next reporting date | June 3, 2015 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $50.0K |
| Annual profit (last year) | -$24.0M |
| Net profit margin | -48,017.12% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Michael Macaluso |
Chief Operating Officer Joshua R. Disbrow |
Corporate headquarters Greenwood Village, Colorado |
